𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson's disease

✍ Scribed by E. Luginger; G. K. Wenning; S. Bösch; W. Poewe


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
95 KB
Volume
15
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Accelerometric assessment of levodopa-in
✍ J.I. Hoff; A.A. v/d Plas; E.A.H. Wagemans; J.J. van Hilten 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

Our objective was to develop parameters for objective ambulatory measurements of levodopa-induced dyskinesias (LID) in patients with Parkinson's disease (PD). Twentythree PD patients with mild to severe LID were submitted to a standardized protocol of 1-minute recordings during rest, talking, stress

Comparative study of selegiline plus L-d
✍ Timothy Brannan; Dr. Melvin D. Yahr 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB

The long-term effect of selegiline (L-deprenyl) in the treatment of Parkinson's disease has not been clearly delineated. We report on a group of patients whose treatment was initiated with selegiline (n = 43) and then subsequently included L-dopa-carbidopa (Sinemet) and in whom an extended period o

The L-dopa on-off effect in parkinson di
✍ L. Direnfeld; L. Spero; J. Marotta; Dr. P. Seeman 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 1 views

## Abstract It has been suggested that patients with Parkinson disease partially compensate for neuron loss by developing denervation supersensitivity, and, if so, that prolonged levodopa (L‐dopa) therapy might lead to desensitization. As a preliminary test of this hypothesis, and in order to study